11 completed, 2 unknown, 1 recruiting, 1 terminated. 6 Phase 3, 4 Phase 2, 2 Not applicable, 2 Phase 4, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 4, Terminated 1, Unknown 1 |
| Phase 2 | 4 | Completed 3, Recruiting 1 |
| Not applicable | 2 | Completed 1, Unknown 1 |
| Phase 4 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Active Rheumatoid Arthritis: new trials by email Literature Review of Active Rheumatoid Arthritis trials Research Report on Active Rheumatoid Arthritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY) ELV001 25 mg, ELV001 75 mg, ELV001 125 mg - Active Rheumatoid Arthritis | Phase 2 | Recruiting | Elevara Medicines Limited | 180 | 2026-02-18 | 2026-10-23 |
| Pulse Steroid Injection in Refractory Rheumatoid Arthritis Solumedrol - Active Rheumatoid Arthritis | Phase 3 | Unknown | Sohag University | 268 | 2024-05-01 | 2024-06-13 |
| Vitamin D Effect in Rheumatoid Arthritis. Ergocalciferol 1.25 mg tablet - Active Rheumatoid Arthritis | Phase 4 | Completed | Tanta University | 20 | 2019-09-06 | 2020-07-15 |
| Evolution of Total Energy Expenditure and Its Various Components in Active Rheumatoid Arthritis (RA)Treated With Anti-TNF Agents and Comparison With Healthy Subjects Energy metabolism of patients suffering from RA - Active Rheumatoid Arthritis | Not applicable | Unknown | University Hospital, Clermont-Ferrand | 24 | 2017-11-30 | 2017-11-21 |
| Clinical Efficacy and Safety of Leflunomide in Egyptian Patients With Active Rheumatoid Arthritis Active Rheumatoid Arthritis | Completed | Eva Pharma | 398 | 2017-06-16 | 2020-06-30 | |
| Study to Demonstrate Non-Inferior Efficacy and Safety of CinnoRA® Versus Humira® for Treatment of Active RA Adalimumab, Methotrexate, Folic Acid - Active Rheumatoid Arthritis | Phase 3 | Completed | Cinnagen | 136 | 2015-11-18 | 2021-02-02 |
| To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With Reference1505 In Subjects With Active Rheumatoid Arthritis Treatment I, Treatment II, Treatment III - Active Rheumatoid Arthritis | Phase 3 | Terminated | Sun Pharmaceutical Industries Limited | 150 | 2015-11-01 | 2021-11-19 |
| Topical Compound Tripterygium Wilfordii Hook F for Patients With Active Rheumatoid Arthritis Topical compound tripterygium, Placebo - Active Rheumatoid Arthritis | Not applicable | Completed | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 70 | 2011-10-01 | 2017-04-28 |
| Long-term Treatment Study of CDP870 Self-injection in Patients With Active Rheumatoid Arthritis Who Are Participating in the Long-term Treatment Studies (Study 275-08-002 or Study 275-08-004) of CDP870 CDP870 - Active Rheumatoid Arthritis | Phase 3 | Completed | Astellas Pharma Inc | 86 | 2011-01-01 | 2015-11-16 |
| Study Evaluating The Efficacy And Safety Of SBI-087 In Seropositive Subjects With Active Rheumatoid Arthritis SBI-087, Placebo - Active Rheumatoid Arthritis | Phase 2 | Completed | Pfizer | 210 | 2009-12-01 | 2013-12-03 |
| Study Evaluating Multiple Doses Of ATN-103 In Subjects With Active Rheumatoid Arthritis ATN-103, Placebo, Methotrexate - Active Rheumatoid Arthritis | Phase 1 / Phase 2 | Completed | Ablynx, a Sanofi company | 252 | 2009-09-01 | 2013-01-30 |
| Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis etanercept - Active Rheumatoid Arthritis, Arthritis, Rheumatoid | Phase 4 | Completed | Pfizer | 306 | 2009-09-01 | 2014-07-17 |
| Safety and Efficacy Study of Tranilast in Patients With Active Rheumatoid Arthritis (RA) Tranilast, Placebo - Active Rheumatoid Arthritis | Phase 2 | Completed | Nuon Therapeutics, Inc. | 250 | 2009-03-01 | 2011-01-06 |
| A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate Abatacept, Placebo - Active Rheumatoid Arthritis | Phase 3 | Completed | Bristol-Myers Squibb | 50 | 2007-05-01 | 2012-01-18 |
| Study Comparing Etanercept Plus Methotrexate to Either Etanercept or Methotrexate Alone in Rheumatoid Arthritis. Etanercept - Active Rheumatoid Arthritis | Phase 3 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 615 | 2000-10-01 | 2023-12-13 |
Arthritis, Rheumatoid (5) · Arthritis (1)
Joint Diseases (6) · Musculoskeletal Diseases (6) · Arthritis (5) · Autoimmune Diseases (5) · Connective Tissue Diseases (5) · Immune System Diseases (5) · Rheumatic Diseases (5) · Skin and Connective Tissue Diseases (5)
Etanercept (2) · Methotrexate (2) · Abatacept (1) · Adalimumab (1) · Certolizumab Pegol (1) · Ergocalciferols (1) · Folic Acid (1) · Methylprednisolone Hemisuccinate (1) · Prednisolone (1) · SBI-087 (1) · Tablets (1) · tranilast (1)
Pfizer (2) · Ablynx, a Sanofi company (1) · Astellas Pharma Inc (1) · Bristol-Myers Squibb (1) · Cinnagen (1) · Elevara Medicines Limited (1) · Eva Pharma (1) · Guang'anmen Hospital of China Academy of Chinese Medical Sciences (1) · Nuon Therapeutics, Inc. (1) · Sohag University (1) · Sun Pharmaceutical Industries Limited (1) · Tanta University (1) · University Hospital, Clermont-Ferrand (1) · Wyeth is now a wholly owned subsidiary of Pfizer (1)
Germany (5) · Belgium (4) · Netherlands (4) · Serbia (4) · Spain (4) · United Kingdom (4) · United States (4) · Egypt (3) · France (3) · Poland (3) · Argentina (2) · Canada (2) · Czechia (2) · Hungary (2) · Italy (2)
Adel Elsayed, MD (1) · Ahmadreza Jamshidi, Professor (1) · Hanaa S EL-banna, MD (1) · Josefin-Beate Holz, MD (1) · Michael Kitt, MD (1) · Quan Jiang (1) · Souzan E Gado, MD (1)
PMID 18050208, PMID 22915624, PMID 25372086, PMID 26535135, PMID 27175292, PMID 27252426, PMID 27486524, PMID 28255449, PMID 28728599, PMID 31277720, PMID 32783547